| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |